Efficacy and safety of recombinant human lymphotoxin-α derivative with cisplatin and fluorouracil in patients with metastatic esophageal squamous cell carcinoma: A randomized, multicenter, open-label, controlled, phase 2b trial. (Record no. 27302567)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02051 a2200589 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517161527.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201710s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1097-0142 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1002/cncr.30845 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Wang, Feng-Hua |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20171011 |
| 245 00 - TITLE STATEMENT | |
| Title | Efficacy and safety of recombinant human lymphotoxin-α derivative with cisplatin and fluorouracil in patients with metastatic esophageal squamous cell carcinoma: A randomized, multicenter, open-label, controlled, phase 2b trial. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Cancer |
| Date of publication, distribution, etc. | Oct 2017 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 3986-3994 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carcinoma, Squamous Cell |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | China |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cisplatin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Esophageal Neoplasms |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Fluorouracil |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lymphotoxin-alpha |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Receptors, Tumor Necrosis Factor, Type II |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Recombinant Proteins |
| General subdivision | adverse effects |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wang, Yun |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sun, Guo-Ping |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chen, Jian-Hua |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lin, Ying-Cheng |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liu, Wei |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zheng, Rong-Sheng |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chen, Jia |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhang, He-Long |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lan, Hai-Tao |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Qi, Jun |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liu, Yang-Qing |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Deng, Yan-Ming |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhao, Heng |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Xiong, Jian-Ping |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Xu, Qing |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jiang, Wen-Qi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Li, Yu-Hong |
| 773 0# - HOST ITEM ENTRY | |
| Title | Cancer |
| Related parts | vol. 123 |
| -- | no. 20 |
| -- | p. 3986-3994 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1002/cncr.30845">https://doi.org/10.1002/cncr.30845</a> |
| Public note | Available from publisher's website |
No items available.